Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile

Hainan Poly Pharm Co Stock

300630.SZ
CNE100002N10

Price

9.88
Today +/-
+0
Today %
+0 %
P

Hainan Poly Pharm Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Hainan Poly Pharm Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hainan Poly Pharm Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hainan Poly Pharm Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Hainan Poly Pharm Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Hainan Poly Pharm Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Hainan Poly Pharm Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hainan Poly Pharm Co’s growth potential.

Hainan Poly Pharm Co Revenue, EBIT and net profit per share

DateHainan Poly Pharm Co RevenueHainan Poly Pharm Co EBITHainan Poly Pharm Co Net Income
2025e2.87 B undefined768.61 M undefined702.7 M undefined
2024e2.45 B undefined672.66 M undefined597.75 M undefined
2023e2.1 B undefined600.95 M undefined506.49 M undefined
20221.81 B undefined468.05 M undefined420.62 M undefined
20211.51 B undefined512.22 M undefined416.6 M undefined
20201.19 B undefined470.1 M undefined407.5 M undefined
2019950.1 M undefined339.9 M undefined301.1 M undefined
2018623.9 M undefined201.4 M undefined181.4 M undefined
2017324.8 M undefined113.2 M undefined98.4 M undefined
2016248 M undefined71.2 M undefined69.8 M undefined
2015202.8 M undefined50.9 M undefined50.7 M undefined
2014164.6 M undefined35.9 M undefined36.7 M undefined

Hainan Poly Pharm Co Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2014201520162017201820192020202120222023e2024e2025e
0.160.20.250.320.620.951.191.511.812.12.452.87
-23.1722.7730.6592.2852.4925.0526.9419.7616.2216.6717.19
73.1774.7576.6183.0283.7981.5874.7571.5565.84---
0.120.150.190.270.520.780.891.081.19000
355071113201339470512468600672768
21.3424.7528.6334.8832.2635.6839.5633.9525.9128.5927.4426.76
36506998181301407416420506597702
-38.8938.0042.0384.6966.3035.222.210.9620.4817.9817.59
------------
------------
315.7315.7315.7394.5421421433.5436.98436.35000
------------
Details

Keystats

ⓘ

Revenue and Growth

The Hainan Poly Pharm Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Hainan Poly Pharm Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Hainan Poly Pharm Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Hainan Poly Pharm Co's financial health and stability.

Assets

Hainan Poly Pharm Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Hainan Poly Pharm Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Hainan Poly Pharm Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Hainan Poly Pharm Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201420152016201720182019202020212022
000000000
000000000
000000000
-71-97-100-144-291-287-267-560-573
000000000
000000000
-26-33-39-38-44-74-51-34-130
5658559394215332157534
-16-41-91-174-252-402-836-803-1,036
-7-55-38-251-167-402-833-973-975
9-1452-778403-16961
000000000
0.04-0.010.02-0.030.020.280.0610.95
000000000
38-51-12281-1233666900742
0-10315-40681-1-82
-1-41-350-19-42-77-100-124
0.240.140.20.40.360.620.810.841.55
39.717-35.7-80.8-157.2-187.1-504.4-646.74-502.58
000000000

Hainan Poly Pharm Co stock margins

The Hainan Poly Pharm Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hainan Poly Pharm Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hainan Poly Pharm Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Hainan Poly Pharm Co's sales revenue. A higher gross margin percentage indicates that the Hainan Poly Pharm Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Hainan Poly Pharm Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Hainan Poly Pharm Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hainan Poly Pharm Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hainan Poly Pharm Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hainan Poly Pharm Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Hainan Poly Pharm Co Margin History

Hainan Poly Pharm Co Gross marginHainan Poly Pharm Co Profit marginHainan Poly Pharm Co EBIT marginHainan Poly Pharm Co Profit margin
2025e65.84 %26.78 %24.48 %
2024e65.84 %27.46 %24.4 %
2023e65.84 %28.63 %24.13 %
202265.84 %25.91 %23.29 %
202171.58 %33.95 %27.61 %
202074.76 %39.55 %34.28 %
201981.6 %35.78 %31.69 %
201883.76 %32.28 %29.08 %
201782.97 %34.85 %30.3 %
201676.73 %28.71 %28.15 %
201574.56 %25.1 %25 %
201473.03 %21.81 %22.3 %

Hainan Poly Pharm Co Stock Sales Revenue, EBIT, Earnings per Share

The Hainan Poly Pharm Co earnings per share therefore indicates how much revenue Hainan Poly Pharm Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hainan Poly Pharm Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hainan Poly Pharm Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hainan Poly Pharm Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hainan Poly Pharm Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Hainan Poly Pharm Co Revenue, EBIT and net profit per share

DateHainan Poly Pharm Co Sales per ShareHainan Poly Pharm Co EBIT per shareHainan Poly Pharm Co Earnings per Share
2025e6.35 undefined0 undefined1.56 undefined
2024e5.42 undefined0 undefined1.32 undefined
2023e4.65 undefined0 undefined1.12 undefined
20224.14 undefined1.07 undefined0.96 undefined
20213.45 undefined1.17 undefined0.95 undefined
20202.74 undefined1.08 undefined0.94 undefined
20192.26 undefined0.81 undefined0.72 undefined
20181.48 undefined0.48 undefined0.43 undefined
20170.82 undefined0.29 undefined0.25 undefined
20160.79 undefined0.23 undefined0.22 undefined
20150.64 undefined0.16 undefined0.16 undefined
20140.52 undefined0.11 undefined0.12 undefined

Hainan Poly Pharm Co business model

Hainan Poly Pharm Co is one of the most popular companies on Eulerpool.com.

Hainan Poly Pharm Co valuation based on historical P/E ratio, EBIT, and P/S ratio.

Hainan Poly Pharm Co shares outstanding

The number of shares was Hainan Poly Pharm Co in 2023 — This indicates how many shares 436.352 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hainan Poly Pharm Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hainan Poly Pharm Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hainan Poly Pharm Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hainan Poly Pharm Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Hainan Poly Pharm Co Stock splits

In Hainan Poly Pharm Co's history, there have been no stock splits.

Hainan Poly Pharm Co Stock Dividend

In 2023, Hainan Poly Pharm Co paid a dividend amounting to 0.08 CNY. Dividend means that Hainan Poly Pharm Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Hainan Poly Pharm Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Hainan Poly Pharm Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Hainan Poly Pharm Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Hainan Poly Pharm Co Dividend History

DateHainan Poly Pharm Co Dividend
2025e0.22 undefined
2024e0.22 undefined
2023e0.22 undefined
20220.19 undefined
20210.19 undefined
20200.14 undefined
20190.09 undefined
20180.05 undefined

Hainan Poly Pharm Co Stock Payout Ratio

In 2023, Hainan Poly Pharm Co had a payout ratio of 18.1%. The payout ratio indicates the percentage of the company's profits that Hainan Poly Pharm Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Hainan Poly Pharm Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Hainan Poly Pharm Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Hainan Poly Pharm Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Hainan Poly Pharm Co Payout Ratio History

DateHainan Poly Pharm Co Payout ratio
2025e19.07 %
2024e19.2 %
2023e18.1 %
202219.9 %
202119.61 %
202014.78 %
201912.69 %
201810.79 %
201718.1 %
201618.1 %
201518.1 %
201418.1 %
Unfortunately, there are currently no price targets and forecasts available for Hainan Poly Pharm Co.

Eulerpool ESG Scorecard© for the Hainan Poly Pharm Co stock

Eulerpool World ESG Rating (EESG©)

33/ 100

🌱 Environment

20

👫 Social

28

🏛️ Governance

50

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

Kontaktformular an uns. The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Hainan Poly Pharm Co Stock Shareholders

%
Name
Stocks
Change
Date
6.87 % Zhu (Xiaoping)31,026,54409/30/2023
32.77 % Fan (Minhua)148,059,50909/30/2023
3.03 % CITIC Securities Co., Ltd. (Asset Management)13,667,208-7,194,9069/30/2023
1.11 % Duan (Lihui)5,000,00009/30/2023
1.08 % Golden Trust Sinopac Fund Management Co., Ltd.4,856,676-84,90012/31/2023
0.94 % Zhong Ou Asset Management Co., Ltd.4,239,813311,5519/30/2023
0.67 % Luo (Bang Yi)3,039,9593,039,9599/30/2023
0.59 % China Life Asset Management Company Limited2,673,1662,673,1669/30/2023
0.41 % Fullgoal Fund Management Co., Ltd.1,850,156-1,345,32412/31/2023
0.24 % Zou (Yinkui)1,062,218-12,00012/31/2022
1
2
3
4
5
...
10

Hainan Poly Pharm Co Executives and Management Board

Ms. Minhua Fan62
Hainan Poly Pharm Co Chairman of the Board, General Manager (since 2012)
Compensation 765,600
Mr. Mao Zhou53
Hainan Poly Pharm Co Deputy General Manager, Secretary of the Board, Director (since 2009)
Compensation 592,800
Mr. Xuelai Zhou44
Hainan Poly Pharm Co Deputy General Manager
Compensation 592,700
Ms. Tongning Luo47
Hainan Poly Pharm Co Chief Financial Officer, Deputy General Manager, Director (since 2012)
Compensation 579,100
Mr. Yinkui Zou56
Hainan Poly Pharm Co Deputy General Manager
Compensation 572,700
1
2

Hainan Poly Pharm Co stock: Frequently Asked Questions

What is the P/E ratio of Hainan Poly Pharm Co 2024?

The Hainan Poly Pharm Co P/E ratio is 7.21.

What is the P/S ratio of Hainan Poly Pharm Co 2024?

The Hainan Poly Pharm Co P/S ratio is 1.76.

What is the AlleAktien quality score of Hainan Poly Pharm Co?

The AlleAktien quality score for Hainan Poly Pharm Co is 5/10.

What is the revenue of Hainan Poly Pharm Co 2024?

The expected Hainan Poly Pharm Co revenue is 2.45 B CNY.

How high is the profit of Hainan Poly Pharm Co 2024?

The expected Hainan Poly Pharm Co profit is 597.75 M CNY.

What is the business model of Hainan Poly Pharm Co

No history available for Hainan Poly Pharm Co.

What is the Hainan Poly Pharm Co dividend?

Hainan Poly Pharm Co pays a dividend of 0.19 CNY distributed over payouts per year.

How often does Hainan Poly Pharm Co pay dividends?

The dividend cannot currently be calculated for Hainan Poly Pharm Co or the company does not pay out a dividend.

What is the Hainan Poly Pharm Co ISIN?

The ISIN of Hainan Poly Pharm Co is CNE100002N10.

What is the Hainan Poly Pharm Co ticker?

The ticker of Hainan Poly Pharm Co is 300630.SZ.

How much dividend does Hainan Poly Pharm Co pay?

Over the past 12 months, Hainan Poly Pharm Co paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.94 %. For the coming 12 months, Hainan Poly Pharm Co is expected to pay a dividend of 0.22 CNY.

What is the dividend yield of Hainan Poly Pharm Co?

The current dividend yield of Hainan Poly Pharm Co is 1.94 %.

When does Hainan Poly Pharm Co pay dividends?

Hainan Poly Pharm Co pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Hainan Poly Pharm Co?

Hainan Poly Pharm Co paid dividends every year for the past 8 years.

What is the dividend of Hainan Poly Pharm Co?

For the upcoming 12 months, dividends amounting to 0.22 CNY are expected. This corresponds to a dividend yield of 2.85 %.

In which sector is Hainan Poly Pharm Co located?

Hainan Poly Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hainan Poly Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hainan Poly Pharm Co from 7/18/2023 amounting to 0.079 CNY, you needed to have the stock in your portfolio before the ex-date on 7/18/2023.

When did Hainan Poly Pharm Co pay the last dividend?

The last dividend was paid out on 7/18/2023.

What was the dividend of Hainan Poly Pharm Co in the year 2023?

In the year 2023, Hainan Poly Pharm Co distributed 0.192 CNY as dividends.

In which currency does Hainan Poly Pharm Co pay out the dividend?

The dividends of Hainan Poly Pharm Co are distributed in CNY.

Other fundamentals and analyses of Hainan Poly Pharm Co in the deep dive.

Our stock analysis for Hainan Poly Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hainan Poly Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.